Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 12 January 2026

Honeywell stock flat as new Google Cloud retail tech lands, Citi trims target ahead of earnings

Honeywell stock flat as new Google Cloud retail tech lands, Citi trims target ahead of earnings

New York, Jan 12, 2026, 15:00 EST — Regular session Shares of Honeywell International Inc (HON.O) ticked up roughly 0.1% to $207.5 in Monday afternoon trading, as investors digested the company’s latest product launches targeting retailers and warehouse operators. The timing is crucial as Honeywell prepares to release its fourth-quarter results and 2026 outlook on Jan. 29. Investors will be watching to see if its automation efforts are translating into more consistent growth and improved margins. (Honeywell) The industrial conglomerate kicks off 2026 with a revamped reporting structure, spotlighting Aerospace Technologies, Building Automation, Industrial Automation, and Process Automation and Technology
12 January 2026
·····
D.R. Horton stock rises as KBW trims target — what Wall Street is watching next

D.R. Horton stock rises as KBW trims target — what Wall Street is watching next

NEW YORK, Jan 12, 2026, 15:07 (ET) — Regular session D.R. Horton’s shares edged up roughly 1% to $158.82 Monday afternoon, even as Keefe Bruyette & Woods lowered its price target on the homebuilder. The firm cut the target to $168 from $175 but kept its market perform rating. (MarketScreener) This move is significant as the sector has been reacting to minor tweaks in rate forecasts and policy talk. Investors are hunting for clues that affordability is improving or that builders might reduce incentives without hurting sales. D.R. Horton faces a key test soon. Investors are gearing up ahead of
12 January 2026
········
SoFi stock slides as CEO Anthony Noto weighs Trump’s 10% credit-card rate cap

SoFi stock slides as CEO Anthony Noto weighs Trump’s 10% credit-card rate cap

New York, January 12, 2026, 14:50 EST — Regular session Shares of SoFi Technologies (SOFI.O) dropped 2.4% to $26.74 in afternoon trading Monday, wiping out earlier gains. The slide came after CEO Anthony Noto highlighted potential growth in personal loans tied to President Donald Trump’s plan to cap credit-card rates. The stock had climbed as high as $28.05 before dipping to a low of $26.22. The rate-cap debate is crucial since SoFi’s lending hinges on customers refinancing costly debt. Should banks tighten credit card lending, personal loans and other non-bank options might step in—if borrowers can still meet the criteria.
12 January 2026
···
Nike stock dips even after Jefferies’ “buy aggressively” call — what NKE investors are watching next

Nike stock dips even after Jefferies’ “buy aggressively” call — what NKE investors are watching next

New York, Jan 12, 2026, 14:43 EST — Regular session Nike shares dropped 0.6% to $65.52 in Monday afternoon trading, despite Jefferies reaffirming its buy rating and naming the sportswear giant its top large-cap pick for 2026. Analyst Randal Konik said he “would buy shares aggressively” ahead of this week’s ICR consumer conference and maintained a $110 price target. (Barron’s) The call arrives just as investors and analysts gather at the ICR Conference in Orlando, a key January event focused on consumer and retail forecasts. Spanning three days, the conference frequently shapes which stocks fund managers favor—and which they avoid—heading
12 January 2026
·····
Lemonade stock hits fresh 52-week high as LMND rallies; traders watch short interest and earnings

Lemonade stock hits fresh 52-week high as LMND rallies; traders watch short interest and earnings

New York, January 12, 2026, 14:55 (ET) — Regular session Lemonade Inc shares surged 7.7% to $85.81 on Monday, pushing higher amid a wave of buying in volatile growth stocks. Earlier in the day, the online insurer’s stock hit $85.99. Lemonade surged to a new 52-week high, snapping its streak of erratic rallies and drawing renewed attention from traders. This is significant because Lemonade remains heavily shorted. Around 20% of its public float was shorted as of Dec. 15. The “days to cover” stands near five, indicating how fast shorts could be squeezed into buying if the stock climbs further.
12 January 2026
·····
Verizon stock slips in regular trade as ex-dividend date hits, earnings loom

Verizon stock slips in regular trade as ex-dividend date hits, earnings loom

New York, Jan 12, 2026, 14:22 EST — Regular session Verizon Communications Inc shares slipped 1.6% to $39.81 by Monday afternoon, following a Friday close of $40.46. During the session, the stock fluctuated between $39.52 and $40.08, with roughly 18.7 million shares traded. The drop follows Verizon’s ex-dividend date, when shares begin trading without the upcoming dividend entitlement. According to Verizon’s investor site, the quarterly dividend is $0.69 per share, with both the ex-dividend and record dates on Jan. 12, and a payment date of Feb. 2. Yahoo Finance shows a forward dividend of $2.76 per share, signaling a yield
12 January 2026
····
Abercrombie & Fitch stock slides 17% after outlook trim puts tariffs back on the tape

Abercrombie & Fitch stock slides 17% after outlook trim puts tariffs back on the tape

NEW YORK, Jan 12, 2026, 14:43 EST — Regular session Shares of Abercrombie & Fitch Co dropped 17.3% to $103.26 in afternoon trading Monday, following a cut to its full-year sales growth forecast and a more cautious holiday-quarter outlook. The stock had climbed as high as $124.75 earlier before falling to a session low of $98.87. The reset came as apparel and footwear companies rolled out early holiday-quarter updates, highlighting a tougher consumer environment ahead of the ICR Conference. Consumer Edge analyst Michael Gunther noted that “value-seeking behavior was on full display” in this morning’s wave of retail pre-announcements, with
12 January 2026
····
Merck (MRK) stock slides as JPMorgan conference tests deal buzz and vaccine risk

Merck (MRK) stock slides as JPMorgan conference tests deal buzz and vaccine risk

New York, January 12, 2026, 14:42 EST — Regular session. Merck & Co shares slipped $1.26, or 1.1%, to $109.27 in Monday afternoon trading. The stock has fluctuated between $111.45 and $108.95 today. Investors want clarity on Merck’s next steps beyond Keytruda and its legacy blockbusters. The upcoming J.P. Morgan Healthcare Conference promises to bring that question into sharp focus. Biotech shares opened the week lower, with the SPDR S&P Biotech ETF slipping 2.1%, according to Barron’s. The report noted hopes for major deals, like a possible Merck bid for Revolution Medicines, but no announcements had emerged by late morning.
12 January 2026
·····
Goldman Sachs stock ticks up as Powell probe threat, rate-cap talk keep banks on edge

Goldman Sachs stock ticks up as Powell probe threat, rate-cap talk keep banks on edge

New York, Jan 12, 2026, 14:29 (EST) — Regular session The Goldman Sachs Group, Inc. (GS) shares climbed 0.6% to $944.73 in Monday’s afternoon trading. So far, the stock has fluctuated between $927.40 and $945.86 during the session. Investors are grappling with two Washington shocks at once: the Trump administration’s threat to indict Federal Reserve Chair Jerome Powell, and President Donald Trump’s push for a one-year cap on credit card interest rates. “We need see some type of action before the market will actually react,” said Jordan Rizzuto, chief investment officer at GammaRoad Capital Partners. Adding to the pressure, fourth-quarter
12 January 2026
·····
Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

New York, Jan 12, 2026, 14:44 ET — Regular session underway Nuvation Bio Inc shares tumbled almost 18% on Monday following news of a licensing deal with Japan’s Eisai and initial sales data for its lung-cancer treatment. The stock slipped 17.7% to $6.62, after fluctuating between $8.34 and $6.32 on roughly 11.4 million shares traded. (SEC) This is crucial now as Nuvation aims to show it’s more than just a development-stage player and can operate as a commercial drugmaker. The market has little patience for any slip in early prescription numbers, even with plenty of cash on hand. The Eisai
12 January 2026
·····
Apellis (APLS) stock slides 15% after $689 mln 2025 revenue preview at JPM conference

Apellis (APLS) stock slides 15% after $689 mln 2025 revenue preview at JPM conference

New York, Jan 12, 2026, 14:41 EST — Regular session Apellis Pharmaceuticals shares dropped almost 15% Monday following the release of preliminary 2025 U.S. sales numbers ahead of its J.P. Morgan Healthcare Conference update. The move put the stock in focus as biotech firms roll out early guidance for the year. Timing is key. The J.P. Morgan meeting tends to trigger sharp, single-day swings as investors reassess everything from product demand to cash burn ahead of the busy earnings season. Apellis is working to bolster confidence in SYFOVRE, its treatment for geographic atrophy, while validating early sales momentum for EMPAVELI
12 January 2026
·····
Mastercard stock drops as Trump’s 10% credit-card rate cap plan rattles card-linked names

Mastercard stock drops as Trump’s 10% credit-card rate cap plan rattles card-linked names

New York, Jan 12, 2026, 14:25 (EST) — Regular session underway. Mastercard Incorporated shares slipped 1.7% to $565.93 in Monday afternoon trading, mirroring a wider drop in card-related stocks. Visa also dropped 1.7%, while American Express tumbled 4.2% during the same session. The moves followed U.S. President Donald Trump’s call to cap credit card interest rates at 10% for one year starting Jan. 20, though he didn’t specify enforcement details. UBS Global analysts noted such a cap would require Congressional approval. Seaport Research’s Bill Ryan added that Trump is revisiting the idea amid rising affordability concerns among voters. (Reuters) Credit
12 January 2026
····
1 … 599 600 601 602 603 … 1,914

Stock Market Today

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 07.02.2026

7 February 2026
LIVEMarkets rolling coverageStarted: February 7, 2026, 12:00 AM ESTUpdated: February 7, 2026, 12:08 AM EST CleanSpark (CLSK) Shares Show Volatility Amid Bitcoin Mining Growth Prospects February 7, 2026, 12:02 AM EST. CleanSpark (CLSK), a bitcoin mining firm, saw a sharp 21.96% rise in one day after a 35.26% decline over 90 days. The company posted $785 million in annual revenue but a net loss of $267 million. Despite recent share price volatility, analysts estimate a fair value of $23.16 per share, more than double the current $10.08 price, reflecting expectations of expansion in mining capacity and improved margins. The valuation
Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop